These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 6678404

  • 1. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS, Wiroreno B, Santosa, Soemantri AG, Hendarto T, Singgih Y.
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 3. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
    Kradolfer F, Schnell R.
    Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
    [No Abstract] [Full Text] [Related]

  • 4. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S, Sasaki M, Kobayashi T, Matsuda T.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract] [Full Text] [Related]

  • 5. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
    Kameda K, Kino C.
    Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intermittent rifampicin treatment of tuberculosis.
    Riska N, Mattson K.
    Scand J Respir Dis Suppl; 1973 Nov; 84():140-4. PubMed ID: 4522069
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modern management of tuberculosis.
    Promisloff RA, Johnston RF.
    Compr Ther; 1979 Oct; 5(10):25-37. PubMed ID: 498742
    [No Abstract] [Full Text] [Related]

  • 17. Daily short course (6 months) chemotherapy for treatment of pulmonary tuberculosis in Nigerians: a preliminary report.
    Onadeko BO, Sofowora EO.
    Afr J Med Med Sci; 1978 Sep; 7(3):175-81. PubMed ID: 108938
    [Abstract] [Full Text] [Related]

  • 18. Some aspects of tuberculous meningitis in Surabaya.
    Chandra B.
    Proc Aust Assoc Neurol; 1976 Sep; 13():73-81. PubMed ID: 1029010
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H, Eule H, Lau W, Kuhnert R, Fanter D, Kahlau U, Schönert E, Werner E.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 Sep; 138(1):146-58. PubMed ID: 4491712
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.